Author Post
Prof Trevor Marshall Foundation Staff
Posted: Fri Apr 13th, 2018 16:00
Article:
https://arstechnica.com/tech-policy/2018/04/curing-disease-not-a-sustainable-business-model-goldman-sachs-analysts-say/
I am often asked why I think many published papers are 'ridiculous over-reaching.' At least now TPTB are being honest about why so many papers keep promising scientific breakthrough after breakthrough, even though very few actually materialize as being useful for treating patients...
Congrats to Beth Mole, PhD, who wrote, and managed to get this expose published:
wrotek member
Joined: Thu Dec 30th, 2004
Location: Wroclaw , Poland
Posts: 3327
Status:
Offline
Posted: Sat Apr 14th, 2018 13:17
That is pretty much common opinion among sick people these days. Healthy folks dont believe it, unless they experience it.
____________________ Borreliosis(4 strains),Bartonella IgG only, reflux,headache TMJD ,chronic pain,chronic fatigue,depression 125D36 Ph1Sep05 Ph2Oct06 Ph3Apr07 in low lux NoIRs 25D<7 Oct06
Current time is 14:37
Parts of this bulletin board may not function unless you enable JavaScript (also called Active Scripting) in your browser.
* We can help you understand chronic disease, but only your physician is licensed to give you medical care *
Powered by
WowBB 1.7 - Entire site Copyright © 2004-2021 Autoimmunity Research Foundation, All Rights Reserved
Click
here to view our PRIVACY POLICY
Page processed in 0.0357 seconds (90% database + 10% PHP). 17 queries executed.